What is a standard approach in a high-risk patient to safely taper off benzodiazepines?

What is a standard approach in a high-risk patient to safely taper off benzodiazepines?

• A. Abrupt cessation with no taper
• B. Outpatient rapid taper over 24 hours
• C. Inpatient detox with a supervised taper
• D. Switching to a nonbenzodiazepine hypnotic and stopping benzodiazepines

Answer: (C)

In high‑risk patients, the safest way to reduce benzodiazepine use is a supervised taper in an inpatient detox setting. This approach provides continuous monitoring of vital signs and mental status, allowing immediate intervention if withdrawal becomes severe or dangerous (such as seizures, delirium, or extreme autonomic instability). It also allows use of a longer‑acting benzodiazepine to cross‑titrate gradually, smoothing the withdrawal process and reducing rebound anxiety and insomnia. The controlled environment enables individualized dosing schedules, readiness to address withdrawal symptoms with adjunctive medications, and coordinated medical and psychosocial support. By contrast, abrupt cessation, a rapid outpatient taper, or attempts to manage withdrawal without a structured, closely monitored plan risk serious complications and relapse. Switching to a nonbenzodiazepine hypnotic does not adequately address withdrawal risks and may perpetuate dependence or inadequate symptom control.

In high‑risk patients, the safest way to reduce benzodiazepine use is a supervised taper in an inpatient detox setting. This approach provides continuous monitoring of vital signs and mental status, allowing immediate intervention if withdrawal becomes severe or dangerous (such as seizures, delirium, or extreme autonomic instability). It also allows use of a longer‑acting benzodiazepine to cross‑titrate gradually, smoothing the withdrawal process and reducing rebound anxiety and insomnia. The controlled environment enables individualized dosing schedules, readiness to address withdrawal symptoms with adjunctive medications, and coordinated medical and psychosocial support. By contrast, abrupt cessation, a rapid outpatient taper, or attempts to manage withdrawal without a structured, closely monitored plan risk serious complications and relapse. Switching to a nonbenzodiazepine hypnotic does not adequately address withdrawal risks and may perpetuate dependence or inadequate symptom control.